| 注册
首页|期刊导航|中国药理学通报|DNA 同源重组修复与乳腺癌的研究进展

DNA 同源重组修复与乳腺癌的研究进展

邱宇凡 胡蕴慧 张瑾

中国药理学通报2016,Vol.32Issue(7):910-914,5.
中国药理学通报2016,Vol.32Issue(7):910-914,5.DOI:10.3969/j.issn.1001-1978.2016.07.006

DNA 同源重组修复与乳腺癌的研究进展

Research progress of relationship between DNA homologous recombination repair and breast cancer

邱宇凡 1胡蕴慧 1张瑾1

作者信息

  • 1. 天津医科大学肿瘤医院乳腺肿瘤三科,国家肿瘤临床医学研究中心,中国天津乳腺癌防治研究中心,乳腺癌防治教育部重点实验室,天津市肿瘤防治重点实验室,天津 300060
  • 折叠

摘要

Abstract

Double-strand DNA breaks ( DSBs) are the most dele-terious events in eukaryotic cells , and there are two major path-ways for repairing them: homologous recombination ( HR ) and non-homologous DNA end joining ( NHEJ ) .BRCA1/2 proteins are key factors in HR repair pathway for DSBs and play an es-sential role in BRCA tumor suppressor network , which maintains genomic integrity and stability .Pathogenic mutations of core genes in this network may damage the DNA repair process and increase the risk of breast cancer .This review summarizes the current reports on the relationship between breast cancer suscep-tibility and mutations of the key factors in DNA HR repair asso-ciated tumor suppressor network , and aims at promoting the pre-vention, molecular diagnosis and precision treatment of the breast cancer patients with aforementioned mutations .

关键词

DNA双链断裂/同源重组修复/乳腺肿瘤/易感基因/抑癌基因/BRCA/化疗

Key words

DNA double-strand DNA breaks/homologous re-combination repair/breast neoplasm/susceptibility gene/tumor suppressor gene/BRCA/chemotherapy

引用本文复制引用

邱宇凡,胡蕴慧,张瑾..DNA 同源重组修复与乳腺癌的研究进展[J].中国药理学通报,2016,32(7):910-914,5.

基金项目

国家自然科学青年基金项目( No 81402408);国家科技支撑计划项目 ()

中国药理学通报

OA北大核心CSCDCSTPCD

1001-1978

访问量0
|
下载量0
段落导航相关论文